Women's perceptions of chemotherapy-induced cognitive side affects on work ability: A focus group study

Journal of Clinical Nursing

Volumn 19, Issue 9-10, 2010, Pages 1362-1370

  Munir, Fehmidah ^a   Burrows, Jodie ^a   Yarker, Joanna ^b   Kalawsky, Katryna ^a   Bains, Manpreet ^a  

^a LOUGHBOROUGH UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cancer; Cognitive function; Nursing; Oncology; Qualitative; Work ability

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; COGNITIVE DEFECT; EMPLOYMENT; FEMALE; HUMAN; INFORMATION PROCESSING; MIDDLE AGED; PSYCHOLOGICAL ASPECT;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COGNITION DISORDERS; EMPLOYMENT; FEMALE; FOCUS GROUPS; HUMANS; MIDDLE AGED;

EID: 77955859299     PISSN: 09621067     EISSN: 13652702     Source Type: Journal    
DOI: 10.1111/j.1365-2702.2009.03006.x     Document Type: Article

References (50)

1. Ahles TA, Saykin AJ. Candidate mechanisms for chemotherapy-induced cognitive changes. Nature Reviews. Cancer 2007, 7:192-201.
2. Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Skalla K, Whedon MB, Bivens S, Mitchell T, Greenberg ER, Silberfarb PM. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Journal of Clinical Oncology 2002, 20:485-493.
3. Amir Z, Neary D, Luker K. Cancer survivors' views of work 3 years post diagnosis: a UK perspective. European Journal of Oncology Nursing 2008, 12:190-197.
4. Bandura A. Self-Efficacy: The Exercise of Control 1997, Freeman, New York
5. Bernhard J, Zahrieh D, Coates AS, Gelber RD, Castiglione-Gertsch M, Murray E, Forbes JF, Perey L, Collins J, Synder R, Rudenstam CM, Crivellari D, Veronesi A, Thurlimann B, Fey MF, Price KN, Goldhirsch A, Hurny C. Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer. British Journal of Cancer 2004, 91:1893-1901.
6. Bernhard J, Zahrieh D, Zhang JJ, Martinelli G, Basser R, Hurny C, Forbes JF, Aebi S, Yeo W, Thurlimann B, Green MD, Colleoni M, Gelber RD, Castiglione-Gertsch M, Price KN, Goldhirsch A, Coates AS. Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer. British Journal of Cancer 2008, 98:25-33.
7. de Boer A, Verbeek J, Spelten E, Uitterhoeve A, Ansink A, de Reijke TM, Kammeijer M, Sprangers M, van Dijk F. Work ability and return-to-work in cancer patients. British Journal of Cancer 2008, 98:1342-1347.
8. Bouknight R, Bradley C, Luo Z. Correlates of return to work for breast cancer survivors. Journal of Clinical Oncology 2006, 24:345-353.
9. Bower JE. Behavioral symptoms in patients with breast cancer and survivors. Journal of Clinical Oncology 2008, 26:768-777.
10. Bradley CJ, Benareck HL. Employment patterns of long-term cancer survivors. Psycho-Oncology 2002, 11:188-198.
11. Bradley CJ, Neumark D, Bednarek HL, Schenk M. Short-term effects of breast cancer on labour market attachment: results from a longitudinal study. Journal of Health Economics 2005, 24:137-160.
12. Broadbent DE, Cooper PF, Fitzgerald P, Parkes KR. The cognitive failures questionnaire (CFQ) and its correlates. British Journal of Clinical Psychology 1982, 21:1-16.
13. Broeckel JA, Jacobsen PB, Horton J, Balducci L, Lyman GH. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. Journal of Clinical Oncology 1998, 16:1689-1696.
14. Breast Cancer Survival Statistics 2008, http://info.cancerresearchuk.org/cancerstats/types/breast/survival/, Cancer Research UK, Available at: (accessed 5 August 2008)
15. Castellon SA, Ganz PA, Petersen L, Abraham L, Greendale GA. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. Journal of Clinical Experimental Neuropsychology 2004, 26:955-969.
16. Chirikos TN, Russell-Jacobs A, Cantor AB. Indirect effects of long-term breast cancer survival. Cancer Practice 2002, 10:248-255.
17. Coyne JC, Palmer SC, Shapiro PJ, Thompson R, DeMichele A. Distress, psychiatric morbidity and prescriptions for psychotropic medication in a breast cancer waiting room sample. General Hospital Psychiatry 2004, 26:121-128.
18. Crabtree BF, Miller WL. A template approach to text analysis: developing and using codebooks. Doing Qualitative Research: Multiple Strategies 1992, 93-109. Crabtree BF, Miller WL. eds, Sage, California, pp
19. Dorval M, Maunsell E, Deschenes L, Brisson J, Masse B. Long-term quality of life after breast cancer: comparison of 8-year survivors with population controls. Journal of Clinical Oncology 1998, 16:487-494.
20. Eifel P, Axelson JA, Costa J, Crowley J, Curran WJ, Deshler A, Fulton S, Hedricks CB, Kemeny M, Kornblith AB, Louis TA, Markman M, Mayer R, Roter D. National Institutes of health consensus development conference statement: adjuvant therapy for breast cancer. Journal of the National Cancer Institute 2001, 93:979-989.
21. Falleti MG, Sanfilippo A, Maruff P, Wieh L, Phillips K-A. The nature and severity of cognitive impairment associated with adjuvant chemotherapyin women with breast cancer: a meta-analysis of the current literature. Brain and Cognition 2005, 59:60-70.
22. Fan HG, Houede-Tchen N, Yi QL, Chemerynsky I, Downie FP, Sabate K, Tannock IF. Fatigue, menopausal symptoms and cognitive function in women after adjuvant chemotherapy for breast cancer: 1 and 2-year follow-up of a prospective controlled study. Journal of Clinical Oncology 2005, 23:8025-8032.
23. Ferguson RJ, Ahles TA, Saykin AJ, McDonald BC, Furstenberg CT, Cole BF, Mott LA. Cognitive-behavioral management of chemotherapy-related cognitive change. Psycho-Oncology 2007, 16:772-777.
24. Henwood KL, Pidgeon NF. Qualitative research and psychological theory. Social Research. Philosophy, Politics and Practice 1993, 14-32. Hammersley M, ed, Sage, London, pp
25. Cognitive Changes Related to Cancer Treatment. Hurricane Voices Breast Cancer Foundation publications, 2007 2007, http://www.hurricanevoices.org/downloads/hv_cognitive_summary.pdf, Hurricane Voices Breast Cancer Foundation, Available at: (accessed 6 August 2008)
26. Jansen C, Miaskowski C, Dodd M, Dowling G. Chemotherapy-induced cognitive impairment in women with breast cancer: a critique of the literature. Oncology Nursing Forum 2005, 32:329-342.
27. Jansen C, Dodd M, Miaskowski C, Dowling GA, Kramer J. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide. Psycho-Oncology 2008, 17:1189-1195.
28. Kaplan HS. A neglected issue: the sexual side effects of current treatments for breast cancer. Journal of Sex and Marital Therapy 1992, 18:3-19.
29. Kennedy F, Haslam C, Munir F, Pryce J. Returning to work following cancer: a qualitative exploratory study into the experience of returning to work following cancer. European Journal of Cancer Care 2007, 16:17-25.
30. Love RR, Leventhal H, Easterling DV, Neranz DR. Side effects and emotional distress during cancer chemotherapy. Cancer 1988, 3:604-612.
31. Main DS, Nowels CT, Cavender TA, Etschmaier M, Steiner F. A qualitative study of work and work return in cancer survivors. Psycho-Oncology 2005, 14:992-1004.
32. Massie MJ. Prevalence of depression in patients with cancer. Journal of the National Cancer Institute. Monographs 2004, 32:57-71.
33. Messias DKH, Yeager KA, Dibble SL, Dodd MJ. Patients' perspectives of fatigue while undergoing chemotherapy. Oncology Nursing Forum 1997, 24:43-48.
34. Morgan DL. Focus Groups as Qualitative Research 1997, 2nd edn, Sage, California
35. Nieuwenhuijsen K, Bos-Ransdorp B, Uitterhoeve LL, Sprangers MA, Verbeek JH. Enhanced provider communication and patient education regarding return to work in cancer survivors following curative treatment: a pilot study. Journal of Occupational Rehabilitation 2001, 16:647-657.
36. Phillips K, Bernhard J. Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions. Oncology Nursing Forum 2003, 30:473-478.
37. Pryce J, Munir F, Haslam C. Cancer survivorship and work: symptoms, supervisor reponse, co-worker disclosure and work adjustment. Journal of Occupational Rehabilitation 2007, 17:83-92.
38. Reiso H, Nygard JF, Jorgensen GS, Holanger R, Soldal D, Bruusgaard D. Back to work: predictors of return to work among patients with back disorders certified as sick: a two-year follow-up study. Spine 2003, 28:1468-1473.
39. Savard J, Simard S, Blanchet J, Ivers H, Morin CM. Prevalence, clinical characteristics and risk factors for insomnia in the context of breast cancer. Sleep 2001, 24:583-590.
40. Schag CA, Ganz PA, Polinsky ML, Fred C, Hirji K, Petersen L. Characteristics of women at risk for psychosocial distress in the year after breast cancer. Journal of Clinical Oncology 1993, 11:783-793.
41. Schagen SB, Muller MJ, Boogerd W, Rosenbrand RM, van Rijin D, Rodenhuis S, van Dam FS. Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. Annals of Oncology 2002, 132:1387-1397.
42. Spelten E, Sprangers M, Verbeek J. Factors reported to influence the return to work of cancer survivors: a literature review. Psycho-Oncology 2002, 11:124-131.
43. Spelten E, Verbeek JH, Uitterhoeve A, Ansink A, van de Lelie J, de Reijke TM, Kammeijer M, de Haes J, Sprangers MA. Cancer, fatigue and the return of patients to work: a prospective cohort study. European Journal of Cancer 2003, 39:1562-1567.
44. Stewart A, Bielajew C, Collins B, Parkinson M, Tomiak E. A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women with breast cancer. The Clinical Neuropsychologist 2006, 20:76-89.
45. Taskila T, Lindbohm L. Factors affecting survivors' employment and work ability. Acta Oncológica 2007, 46:446-451.
46. Vardy J, Rourke S, Tannock IF. Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. Journal of Clinical Oncology 2007, 25:2455-2463.
47. Visser A, Huizinga GA, van-der Graaf WT, Hoekstra HJ, Hoekstra-Weebers JE. The impact of parental cancer onchildren and the family. A review of the literature. Cancer Treatment Reviews 2004, 30:683-694.
48. Waddell G, Burton AK. Is work Good for your Health and Well-being? 2006, The Stationary Office, London
49. Wefel JS, Lenzi R, Teriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 2004, 100:2292-2299.
50. Weuve J, Kang JH, Manson JE, Breteler MM, Ware JH, Grodstein F. Physical activity, including walking and cognitive function in older women. JAMA: Journal of the American Medical Association 2004, 12:1454-1464.